Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Dermal absorption

Currently viewing:

Administrative data

Endpoint:
dermal absorption
Type of information:
other: expert statement
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
Well documented expert statement from an internationally recognized contract research organization. The expert statement has been based on a series of physicochemical and toxicology studies performed according to technical guidelines and in compliance with GLP in internationally recognized contract research organizations.
Cross-referenceopen allclose all
Reason / purpose for cross-reference:
reference to same study
Reason / purpose for cross-reference:
reference to other study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2009
Report date:
2009

Materials and methods

Test guideline
Qualifier:
no guideline required
Principles of method if other than guideline:
Expert statement based on a series of physicochemical and toxicology studies. Technical guidelines followed in these experimental studies are cited in the respective endpoint study records.
GLP compliance:
no
Remarks:
Considered unnecessary fo expert statement

Test material

Reference
Name:
Unnamed
Type:
Constituent
Radiolabelling:
no

Test animals

Species:
other: Detailed in endpoint study records of in-vivo studies referred to in the present expert statement
Strain:
other: Detailed in endpoint study records of in-vivo studies referred to in the present expert statement
Sex:
male/female
Details on test animals or test system and environmental conditions:
Detailed in the endpoint study records of in-vivo studies referred to in the present expert statement.

Administration / exposure

Type of coverage:
other: Detailed in endpoint study records of in-vivo studies referred to in the present expert statement, if appropriate.
Vehicle:
other: Detailed in endpoint study records of in-vivo studies referred to in the present expert statement, if appropriate
Duration of exposure:
Detailed in endpoint study records of in-vivo studies referred to in the present expert statement, if appropriate.
Doses:
Detailed in endpoint study records of in-vivo studies referred to in the present expert statement.
No. of animals per group:
Detailed in endpoint study records of in-vivo studies referred to in the present expert statement.
Control animals:
no
Remarks:
Detailed in endpoint study records referred to in the present expert statement, if applicable
Details on study design:
Detailed in endpoint study records referred to in the present expert statement, if applicable

Results and discussion

Signs and symptoms of toxicity:
not specified
Remarks:
Detailed in endpoint study records of in-vivo studies referred to in the present expert statement.
Dermal irritation:
not specified
Remarks:
Detailed in endpoint study records of in-vivo studies referred to in the present expert statement.
Percutaneous absorption
Parameter:
percentage
Absorption:
10 %
Remarks on result:
other: Expert statement, based on MW > 500 and log Pow < -1

Applicant's summary and conclusion